These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2948607)

  • 1. Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.
    Thomas EJ; Jenkins J; Lenton EA; Cooke ID
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1407-8. PubMed ID: 2948607
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
    Williams MR; Walker KJ; Turkes A; Blamey RW; Nicholson RI
    Br J Cancer; 1986 May; 53(5):629-36. PubMed ID: 2941044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.
    Williams G; Kerle D; Griffin S; Dunlop H; Bloom SR
    Br Med J (Clin Res Ed); 1984 Dec; 289(6458):1580-1. PubMed ID: 6239674
    [No Abstract]   [Full Text] [Related]  

  • 4. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
    Costantini S; Anserini P; Valenzano M; Remorgida V; Venturini PL; De Cecco L
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):63-9. PubMed ID: 2142921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women.
    Matta WH; Shaw RW; Burford GD
    Fertil Steril; 1988 Jan; 49(1):163-5. PubMed ID: 2961621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex.
    Holdaway IM; Parr CE; France J
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):164-5. PubMed ID: 1834050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goserelin depot in the treatment of premenopausal advanced breast cancer.
    Blamey RW; Jonat W; Kaufmann M; Bianco AR; Namer M
    Eur J Cancer; 1992; 28A(4-5):810-4. PubMed ID: 1388037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer.
    Walker KJ; Walker RF; Turkes A; Robertson JF; Blamey RW; Griffiths K; Nicholson RI
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):651-4. PubMed ID: 2523808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.
    Lumsden MA; West CP; Hillier H; Baird DT
    Fertil Steril; 1989 Dec; 52(6):924-9. PubMed ID: 2531684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pre-menopausal advanced breast cancer with goserelin--a long-acting luteinizing hormone releasing hormone agonist.
    Brambilla C; Escobedo A; Artioli R; Lechuga MJ; Motta M
    Anticancer Drugs; 1992 Feb; 3(1):3-8. PubMed ID: 1535804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
    Kaufmann M; Jonat W; Schachner-Wünschmann E; Bastert G; Maass H
    Onkologie; 1991 Feb; 14(1):22-4, 26-8, 30. PubMed ID: 1829149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
    Robinson MR; Denis L; Mahler C; Walker K; Stitch R; Lunglmayr G
    Eur J Surg Oncol; 1985 Jun; 11(2):159-65. PubMed ID: 3159598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
    Filicori M; Flamigni C; Cognigni G; Dellai P; Arnone R; Falbo A; Capelli M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):130-3. PubMed ID: 8325935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).
    Lukkarinen O; Kontturi M
    Scand J Urol Nephrol Suppl; 1988; 110():109-12. PubMed ID: 2973121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zoladex as a depot GnRH agonist in premenopausal metastatic breast cancer].
    Schmid H; Schachner-Wünschmann E; Kaufmann M
    Arch Gynecol Obstet; 1989; 245(1-4):741-3. PubMed ID: 2529825
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.
    Walker KJ; Turkes A; Williams MR; Blamey RW; Nicholson RI
    J Endocrinol; 1986 Nov; 111(2):349-53. PubMed ID: 2947964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
    Kaufmann M; Jonat W; Kleeberg U; Eiermann W; Jänicke F; Hilfrich J; Kreienberg R; Albrecht M; Weitzel HK; Schmid H
    J Clin Oncol; 1989 Aug; 7(8):1113-9. PubMed ID: 2526863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
    Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
    Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
    Venturini PL; Fasce V; Costantini S; Anserini P; Cucuccio S; de Cecco L
    Fertil Steril; 1990 Dec; 54(6):1021-7. PubMed ID: 2147154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
    Candiani GB; Vercellini P; Fedele L; Arcaini L; Bianchi S; Candiani M
    Acta Obstet Gynecol Scand; 1990; 69(5):413-5. PubMed ID: 2148663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.